Purpose: Options for single-agent fluoropyrimidine adjuvant therapy after bowel cancer resection include intravenous fluorouracil with leucovorin (FU/LV) or oral capecitabine.

• 目的：肠道肿瘤切除术后氟脲嘧啶类单药辅助化疗可选四氢叶酸联合氟尿嘧啶持续静脉灌注（FU/LV）或者口服卡培它滨。